MiNK Therapeutics stockholders approve 1-for-10 reverse stock split effective Jan 28

MiNK Therapeutics, Inc.

Special meeting held Jan 17, 2025; 27,582,512 shares voted (quorum).
Proposal approved with 26,500,274 For, 1,026,255 Against, 56,013 Abstain.
Reverse split ratio 1-for-10, effective 12:01 a.m. ET on Jan 28, 2025.
Post-split shares trade under new CUSIP 603693 201 on Nasdaq.
39,630,402 shares outstanding pre-split as of record date Dec 16, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.